PHILADELPHIA — Claudio Giraudo, PhD, assistant professor of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania and The Children's Hospital of Philadelphia was named as a 2013 Pew Scholar in the Biomedical Sciences.
Twenty-two of the nation’s most enterprising researchers were named Pew Scholars by The Pew Charitable Trusts. The scholarships provide flexible funding to early-career scientists researching the basis of perplexing health problems. The new scholars join a prestigious community of researchers who have gone on to become Nobel laureates, MacArthur fellows, Albert Lasker Basic Medical Research Award winners, and hundreds of other pioneers who earned Pew grants at the start of their careers.
"The Pew Scholar Award will significantly contribute to building up a strong foundation for my research focused on regulation of the immune response against viral infections and cancer,” says Giraudo. “In particular, this award will give me the chance to study what happens at the cell membrane during the body’s immune response, which could be therapeutically targeted to improve prognosis and quality of life of patients."
“The Pew scholars program gives innovative scientists both the freedom to take calculated risks and the resources to pursue the most promising, but untried, avenues for scientific breakthroughs,” said Rebecca W. Rimel, president and CEO of Pew. “Pew funding provides an ‘insurance policy,’ allowing our scientists to be adventurous with their research. Though their scientific fields are diverse, their commitment is uniform: harnessing scientific discovery to improve human health.”
The scholars program, launched in 1985, has granted more than $120 million in funding to more than 500 scientists at the beginning of their independent careers. The rigorously competitive program awards recipients $240,000 over four years to pursue their projects without direction or restriction. To be considered, applicants must demonstrate excellence and creativity in their research. This year, 179 institutions were invited to nominate a candidate, and 134 eligible nominations were received.
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $5.3 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 17 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $409 million awarded in the 2014 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center -- which are recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report -- Chester County Hospital; Lancaster General Health; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2014, Penn Medicine provided $771 million to benefit our community.
Department of Communications
For Patients and the General Public: